Structure Based Drug Design of Crizotinib (PF-02341066), a Potent and Selective Dual Inhibitor of Mesenchymal–Epithelial Transition Factor (c-MET) Kinase and Anaplastic Lymphoma Kinase (ALK) | Journal of Medicinal Chemistry
Кошелек мужской DANIELE DONATI 05.1190.00 цена | pigu.lt
Doing Business in a More Transparent World by Merar Investment Network - Issuu